Key measures to improve the efficacy of diagnosis and treatment of gastric cancer with peritoneal metastasis
10.3760/cma.j.cn441530-20250304-00080
- VernacularTitle:改善胃癌腹膜转移诊治疗效的关键举措
- Author:
Zhenggang ZHU
1
Author Information
1. 上海交通大学医学院附属瑞金医院外科 上海消化外科研究所 上海市胃肿瘤重点实验室，上海 200025
- Publication Type:Journal Article
- Keywords:
Stomach neoplasms;
Peritoneal metastasis;
Combination therapy;
Conversion surgery
- From:
Chinese Journal of Gastrointestinal Surgery
2025;28(5):450-454
- CountryChina
- Language:Chinese
-
Abstract:
Once peritoneal metastasis occurs, the prognosis of gastric cancer is extremely poor, and the median survival time is only about 6-9 months. In recent years, the clinical research on peritoneal metastasis of gastric cancer has become a hot spot. Based on the research results at home and abroad, the author put forward several important measures, which will contribute to further improve the curative effect of gastric cancer with peritoneal metastasis. (1) Improving the preoperative diagnostic rate of peritoneal metastasis is a prerequisite factor; (2) actively preventing peritoneal metastasis is the priority strategy; (3) combining systemic and intraperitoneal therapy is the key mode. (4) performing radical conversion surgery is the fundamental means. In this paper, the above important issues are discussed to communicate with colleagues.
